Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Rimiducid

EU orphan designation number: EU/3/16/1666   
Active ingredient: Rimiducid
Indication: Treatment of graft-versus-host disease
Sponsor: Bellicum Pharma GmbH
Josephspitalstrasse 15, Altstadt-Lehel, 80331 Munich, Bavaria, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/06/2016 Orphan designation EMA/OD/017/16 (2016)3422 of 30/05/2016
10/05/2017 Transfer of orphan designation EMA/OD/017/16/T/01 (2017)3189 of 8/05/2017
25/02/2019 Transfer of orphan designation EMA/OD/0000004057 (2019)1629 of 21/02/2019